Prospective open label study of solifenacin for overactive bladder in children

Journal of Urology

Volumn 184, Issue 4 SUPPL., 2010, Pages 1668-1673

  Bolduc, Stéphane ^a   Moore, Katherine ^a   Nadeau, Genevive ^a   Lebel, Sylvie ^a   Lamontagne, Pascale ^a   Hamel, Micheline ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

cholinergic antagonists; oxybutynin; tolterodine; urinary bladder, overactive; urination disorders

Indexed keywords

OXYBUTYNIN; SOLIFENACIN; TOLTERODINE; MUSCARINIC RECEPTOR BLOCKING AGENT; QUINUCLIDINE DERIVATIVE; TETRAHYDROISOQUINOLINE DERIVATIVE;

ARTICLE; BLURRED VISION; CHILD; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; OVERACTIVE BLADDER; PRIORITY JOURNAL; QUESTIONNAIRE; URINE INCONTINENCE; URODYNAMICS; XEROSTOMIA; PROSPECTIVE STUDY; URINARY BLADDER, NEUROGENIC; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

CHILD; FEMALE; HUMANS; MALE; MUSCARINIC ANTAGONISTS; PROSPECTIVE STUDIES; QUINUCLIDINES; TETRAHYDROISOQUINOLINES; URINARY BLADDER, NEUROGENIC; URINARY BLADDER, OVERACTIVE; URINARY INCONTINENCE;

EID: 79959259116     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.03.124     Document Type: Article

References (27)

1. P. Abrams, and K.E. Andersson Muscarinic receptor antagonists for overactive bladder BJU Int 100 2007 987
2. C.R. Chapple, T. Rechberger, and S. Al-Shukri Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder BJU Int 93 2004 303
3. K. Youdim, and B.A. Kogan Preliminary study of the safety and efficacy of extended-release oxybutynin in children Urology 59 2002 428
4. S. Bolduc, J. Upadhyay, and J. Payton The use of tolterodine in children after oxybutynin failure BJU Int 91 2003 398
5. S. Ayan, K. Kaya, and K. Topsakal Efficacy of tolterodine as a first-line treatment for non-neurogenic voiding dysfunction in children BJU Int 96 2005 411
6. N. Kilic, E. Balkan, and S. Akgoz Comparison of the effectiveness and side-effects of tolterodine and oxybutynin in children with detrusor instability Int J Urol 13 2006 105
7. R.J. Nijman, N.G. Borgstein, and P. Ellsworth Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials J Urol 173 2005 1334
8. Y. Reinberg, J. Crocker, and J. Wolpert Therapeutic efficacy of extended release oxybutynin chloride, and immediate release and long acting tolterodine tartrate in children with diurnal urinary incontinence J Urol 169 2003 317
9. A. Raes, P. Hoebeke, and I. Segaert Retrospective analysis of efficacy and tolerability of tolterodine in children with overactive bladder Eur Urol 45 2004 240
10. N. Zinner, L. Noe, and L. Rasouliyan Impact of solifenacin on resource utilization, work productivity and health utility in overactive bladder patients switching from tolterodine ER Curr Med Res Opin 24 2008 1583
11. P. Hoebeke, J. De Pooter, and K. De Caestecker Solifenacin for therapy resistant overactive bladder J Urol 182 2009 2040
12. T. Neveus, A. von Gontard, and P. Hoebeke The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children's Continence Society J Urol 176 2006 314
13. K.S. Coyne, L.S. Matza, and Z. Kopp The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder Eur Urol 49 2006 1079
14. B.R. Sommer, R. O'Hara, and N. Askari The effect of oxybutynin treatment on cognition in children with diurnal incontinence J Urol 173 2005 2125
15. K.M. Giramonti, B.A. Kogan, and L.F. Halpern The effects of anticholinergic drugs on attention span and short-term memory skills in children Neurourol Urodyn 27 2008 315
16. M.B. Chancellor, N. Zinner, and K. Whitmore Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: results of a 12-week, multicenter, open-label, flexible-dose study Clin Ther 30 2008 1766
17. S.M. Gilbert, and T.W. Hensle Metabolic consequences and long-term complications of enterocystoplasty in children: a review J Urol 173 2005 1080
18. T.W. Hensle, and S.M. Gilbert A review of metabolic consequences and long-term complications of enterocystoplasty in children Curr Urol Rep 8 2007 157
19. P.D. Metcalfe, A.J. Casale, and M.A. Kaefer Spontaneous bladder perforations: a report of 500 augmentations in children and analysis of risk J Urol 175 2006 1466
20. D.A. Husmann, and S.R. Rathbun Long-term follow up of enteric bladder augmentations: the risk for malignancy J Pediatr Urol 4 2008 381
21. J.G. Blaivas, J.P. Weiss, and P. Desai Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease J Urol 173 2005 1631
22. L.A. Guerra, D. Moher, and M. Sampson Intravesical oxybutynin for children with poorly compliant neurogenic bladder: a systematic review J Urol 180 2008 1091
23. B. Schurch, and J. Corcos Botulinum toxin injections for paediatric incontinence Curr Opin Urol 15 2005 264
24. T.J. Roth, D.R. Vandersteen, and P. Hollatz Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children J Urol 180 2008 306
25. H.A. Allen, J.C. Austin, and M.A. Boyt Initial trial of timed voiding is warranted for all children with daytime incontinence Urology 69 2007 962
26. M.J. Curran, M. Kaefer, and C. Peters The overactive bladder in childhood: long-term results with conservative management J Urol 163 2000 574
27. R.L. Collins, P.L. Ellickson, and D. McCaffrey Early adolescent exposure to alcohol advertising and its relationship to underage drinking J Adolesc Health 40 2007 527